Joseph Edelman – PTGX history
- Issuer:
- PROTAGONIST THERAPEUTICS INC
- Quarters tracked:
- 15 (Q4 2020 → Q1 2026)
- Current shares:
- 1,230,879
- Current value:
- $129.74M
- Peak shares:
- 1,469,761 (Q2 2023)
- Overall change:
- +505%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 1,230,879 | $129.74M | $105.40 | -119,546 | -9% |
| Q4 2025 | 1,350,425 | $117.95M | $87.34 | +320,291 | +31% |
| Q3 2025 | 1,030,134 | $68.43M | $66.43 | -44,314 | -4% |
| Q2 2025 | 1,074,448 | $59.38M | $55.27 | -16,823 | -2% |
| Q1 2025 | 1,091,271 | $52.77M | $48.36 | -180,391 | -14% |
| Q4 2024 | 1,271,662 | $49.09M | $38.60 | -102,901 | -7% |
| Q3 2024 | 1,374,563 | $61.85M | $45.00 | +105,828 | +8% |
| Q2 2024 | 1,268,735 | $43.96M | $34.65 | +274,412 | +28% |
| Q1 2024 | 994,323 | $28.77M | $28.93 | +611,063 | +159% |
| Q4 2023 | 383,260 | $8.79M | $22.93 | -671,013 | -64% |
| Q3 2023 | 1,054,273 | $17.59M | $16.68 | -415,488 | -28% |
| Q2 2023 | 1,469,761 | $40.59M | $27.62 | +504,609 | +52% |
| Q1 2023 | 965,152 | $22.20M | $23.00 | +965,152 | +100% |
| Q1 2021 | SOLD | — | — | -203,591 | -100% |
| Q4 2020 | 203,591 | $4.10M | $20.16 | — | NEW |